Benzinga's Top Pre-Market Losers
Progenics Pharmaceuticals (NASDAQ: PGNX) shares fell 47.22% to $5.70 in the pre-market trading. Salix Pharmaceuticals Ltd (NASDAQ: SLXP) and Progenics Pharmaceuticals received a Complete Response Letter from the US Food and Drug Administration (FDA) for a Supplemental New Drug Application (sNDA) for RELISTOR.
Salix Pharmaceuticals Ltd (NASDAQ: SLXP) dipped 15.42% to $44.99 in the pre-market session. Analysts at Susquehanna downgraded Salix from “positive” to “neutral.”
Green Mountain Coffee Roasters (NASDAQ: GMCR) moved down 1.88% to $17.70 in the pre-market session. Green Mountain Coffee Roasters shares have dropped 82.65% over the past 52 weeks, while the S&P 500 index has gained 7.25% in the same period.
Masco (NYSE: MAS) dipped 1.58% to $13.09 in the pre-market session. Masco is expected to report its Q2 earnings after the closing bell.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.